Use of pridopidine for treating rett syndrome

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 12102627
SERIAL NO

16952123

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The subject invention provides a method for treating a subject afflicted with Rett syndrome comprising administering to the subject an effective amount of pridopidine so as to thereby treat the subject.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PRILENIA NEUROTHERAPEUTICS LTDYAKUM GREENWORK BUSINESS PARK MINDSPACE OFFICES BUILDING D 6097200 YAKUM ISRAEL

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Geva, Michal Even-Yehuda, IL 30 174
Hayden, Michael Herzliya, IL 76 372
Laufer, Ralph Tel Aviv, IL 21 25

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Apr 1, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 1, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 1, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00